These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12447877

  • 21. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
    Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y, Kaneki M.
    Oncogene; 2006 Jan 12; 25(2):176-85. PubMed ID: 16170353
    [Abstract] [Full Text] [Related]

  • 22. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
    Li JC, Li R.
    Cancer Res; 2007 Sep 15; 67(18):8856-64. PubMed ID: 17875727
    [Abstract] [Full Text] [Related]

  • 23. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT.
    Mol Cell Biol; 2007 May 15; 27(10):3569-77. PubMed ID: 17325037
    [Abstract] [Full Text] [Related]

  • 24. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH, Fleming IN, Downes CP.
    Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130
    [Abstract] [Full Text] [Related]

  • 25. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
    Wang C, Buck DC, Yang R, Macey TA, Neve KA.
    J Neurochem; 2005 May 01; 93(4):899-909. PubMed ID: 15857393
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
    Rubin R, Harrison R, Chen XF, Corzitotto J, Hoek JB, Hallak H.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2009-17. PubMed ID: 15476672
    [Abstract] [Full Text] [Related]

  • 27. Src tyrosine kinase regulates insulin-induced activation of protein kinase C (PKC) delta in skeletal muscle.
    Rosenzweig T, Aga-Mizrachi S, Bak A, Sampson SR.
    Cell Signal; 2004 Nov 15; 16(11):1299-308. PubMed ID: 15337529
    [Abstract] [Full Text] [Related]

  • 28. Effect of EGF on [3H]-thymidine incorporation and cell cycle regulatory proteins in primary cultured chicken hepatocytes: Involvement of Ca2+/PKC and MAPKs.
    Lee MY, Lee SH, Kim YH, Heo JS, Park SH, Lee JH, Han HJ.
    J Cell Biochem; 2006 Dec 15; 99(6):1677-87. PubMed ID: 16823772
    [Abstract] [Full Text] [Related]

  • 29. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R, Vasilcanu D, Sehat B, Yin S, Girnita A, Axelson M, Girnita L.
    Mol Pharmacol; 2008 Mar 15; 73(3):930-9. PubMed ID: 18070930
    [Abstract] [Full Text] [Related]

  • 30. The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone.
    Luo L, Yano N, Luo JZ.
    Am J Physiol Endocrinol Metab; 2006 May 15; 290(5):E889-99. PubMed ID: 16603724
    [Abstract] [Full Text] [Related]

  • 31. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D, Patil S, Li W, Humphrey LE, Brattain MG, Howell GM.
    Oncogene; 2002 Apr 25; 21(18):2785-96. PubMed ID: 11973637
    [Abstract] [Full Text] [Related]

  • 32. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ, Yenson VM, Baxter RC.
    Mol Cell Endocrinol; 2013 Sep 05; 377(1-2):56-64. PubMed ID: 23831640
    [Abstract] [Full Text] [Related]

  • 33. Suppression of epidermal growth factor-induced phospholipase C activation associated with actin rearrangement in rat hepatocytes in primary culture.
    Nojiri S, Hoek JB.
    Hepatology; 2000 Nov 05; 32(5):947-57. PubMed ID: 11050044
    [Abstract] [Full Text] [Related]

  • 34. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ.
    Endocrinology; 2007 Aug 05; 148(8):4091-101. PubMed ID: 17525128
    [Abstract] [Full Text] [Related]

  • 35. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
    Najjar SM, Blakesley VA, Li Calzi S, Kato H, LeRoith D, Choice CV.
    Biochemistry; 1997 Jun 03; 36(22):6827-34. PubMed ID: 9184166
    [Abstract] [Full Text] [Related]

  • 36. Endosomal signalling of epidermal growth factor receptors contributes to EGF-stimulated cell cycle progression in primary hepatocytes.
    Luo Y, Cheng Z, Dixon CJ, Hall JF, Taylor E, Boarder MR.
    Eur J Pharmacol; 2011 Mar 05; 654(2):173-80. PubMed ID: 21172338
    [Abstract] [Full Text] [Related]

  • 37. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
    Zahradka P, Litchie B, Storie B, Helwer G.
    Endocrinology; 2004 Jun 05; 145(6):2978-87. PubMed ID: 14976148
    [Abstract] [Full Text] [Related]

  • 38. IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II.
    Zahradka P, Storie B, Wright B.
    Can J Physiol Pharmacol; 2009 Oct 05; 87(10):805-12. PubMed ID: 19898563
    [Abstract] [Full Text] [Related]

  • 39. Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells.
    Bouallegue A, Vardatsikos G, Srivastava AK.
    Can J Physiol Pharmacol; 2010 May 05; 88(5):501-9. PubMed ID: 20555420
    [Abstract] [Full Text] [Related]

  • 40. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
    Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, Weinstein IB, Moriwaki H.
    Cancer Lett; 2008 Apr 08; 262(1):10-8. PubMed ID: 18164805
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.